Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma

American Journal of Surgery

Volumn 186, Issue 2, 2003, Pages 194-200

  Margenthaler, Julie A ^a,b   Meier, Jeremy D ^a,b   Virgo, Katherine S ^a,b   Johnson, David Y ^b   Goshima, Kaoru ^a,b   Chan, Danny ^a,b   Handler, Barry S ^a,b   Johnson, Frank E ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cutaneous melanoma; Follow up; Geographic variation; Survey

Indexed keywords

ALPHA FETOPROTEIN; CYSTEINYLDOPA;

ABDOMEN; AMBULATORY CARE; ANALYSIS OF VARIANCE; ARTICLE; BONE SCINTISCANNING; BRAIN; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE ORGANIZATION; MEDICAL PRACTICE; MEDICAL SOCIETY; MELANOMA; PATIENT CARE; PATIENT MONITORING; PLASTIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICS; THORAX RADIOGRAPHY; UNITED STATES; CLINICAL PRACTICE; CLUSTER ANALYSIS; GEOGRAPHY; HEALTH; MASS SCREENING; POPULATION RESEARCH; SKIN TUMOR; UTILIZATION REVIEW;

CENSUSES; CONTINUITY OF PATIENT CARE; GEOGRAPHY; HUMANS; MASS SCREENING; MELANOMA; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SKIN NEOPLASMS; SMALL-AREA ANALYSIS; SURGERY, PLASTIC; UNITED STATES; URBAN HEALTH;

EID: 0042661274     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00179-X     Document Type: Article

References (33)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics. Cancer J Clin. 49:1999;8-31.
2. Gupta B.K., Piedmonte M.R., Karakousis C.P. Attributes and survival patterns of multiple primary cutaneous malignant melanoma. Cancer. 67:1991;1984-1989.
3. Russell L.B. Screening for cervical cancer. Russell L.B. Educated guesses making policy about medical screening tests . 1994;6-24 University of California Press, Los Angeles.
4. Kolata G. Questions grow over usefulness of some routine cancer tests. The New York Times, page 1, section A, December 30, 2001.
5. The survey instrument. Available at: http://medschool.slu.edu/ departments/surgery/fac/johnson/questl.shtml.
6. Chan D., Virgo K.S., Handler B.S., et al. Current practice of patient follow-up after potentially curative resection of cutaneous melanoma. Plast Recon Surg. 106:2000;590-597.
7. Wennberg J., Gittlesohn A. Variation in medical care among small areas. Sci Am. 246:1982;120-134.
8. County and city data book: 1994. 1994;U.S. Government Printing Office, Washington, DC.
9. Kertesz L. The game of risk providers fight back . Mod Healthcare. 26:1996;24-29.
10. Provost N., Marghoob A.A., Kopf A.W., et al. Laboratory tests and imaging studies in patients with cutaneous malignant melanomas a survey of experienced physicians . J Am Acad Dermatol. 36:1997;711-720.
11. Coit D.G. Cutaneous melanoma. Johnson F.E., Virgo K.S. Cancer patient follow-up. 1997;268-275 CV Mosby, St. Louis.
12. Powe N.R., Steiner C.A., Anderson G.F., et al. Awareness of providers' use of new medical technology among private health care plans in the United States. Int J Technol Assess Health Care. 12:1996;367-376.
13. Steiner C., Powe N.R., Anderson G.F., et al. Technology coverage decisions by health care plans and considerations by medical directors. Med Care. 35:1997;472-489.
14. Hermann R.C. Variation in ECT use in the USA. Am J Psychiatry. 52:1995;869-875.
15. Chassin M.R., Galvin R.W. The urgent need to improve health care quality. JAMA. 280:1998;1000-1005.
16. Poo-Hwu W.J., Ariyan S., Lamb L., et al. Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma. Cancer. 86:1999;2252-2258.
17. Chitwood D.D. National surveys are they helpful? Ann Thorac Surg. 59:1995;275-276.
18. Rosenau P.V. Managing medical technology lessons for the United States from Quebec and France . Int J Health Serv. 30:2000;617-639.
19. Dozet A., Fischer L. Incentives for diffusion of new health care technology. Dev Health Econ Public Policy. 7:1998;161-185.
20. Yamamoto S., Watanabe S. Geographic characteristics and mortality profiles in the JPHC study Japan Public Health Center-based prospective study on cancer and cardiovascular diseases . J Epidemiol. 11:2001;S8-23.
21. Birkmeyer J.D., Sharp S.M., Finlayson S.R., et al. Variation profiles of common surgical procedures. Surgery. 124:1998;917-923.
22. Diehr P., Cain K.C., Kreuter W., et al. Can small-area variation analysis detect variation in surgery rates? Med Care. 30:1992;484-502.
23. Coyte P.C., Croxford R., Asche C.V., et al. Physician and population determinants of rates of middle-ear surgery in Ontario. JAMA. 286:2001;2128-2135.
24. Wright J.G., Hawker G.A., Bombardier C., et al. Physician enthusiasm as an explanation for area variation in the utilization of knee replacement surgery. Med Care. 37:1999;946-956.
25. Powell T.M., Thompsen J.P., Virgo K.S., et al. Geographic variation in patient surveillance after radical prostatectomy. Ann Surg Oncol. 7:2000;339-345.
26. Cooper G.S., Yuan Z., Chak A., et al. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer. 85:1999;2124-2131.
27. Goldberg K.C., Hartz A.J., Jacobsen S.J., et al. Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. JAMA. 267:1992;1473-1477.
28. Nattinger A.B., Gottlieb M.S., Veum J., et al. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 326:1992;1102-1107.
29. Mooney M.M., Kulas M., McKinley G., et al. Impact on survival by method and recurrence detection in stage I and II cutaneous melanoma. Ann Surg Oncol. 5:1997;54-63.
30. Weiss M., Loprinzi C.L., Creagan E.T., et al. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA. 274:1995;1703-1705.
31. Mooney M.M., Mettlin C., Michalek A.M., et al. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences. Cancer. 80:1997;1052-1064.
32. Romero J.B., Stefanato C.M., Kopf A.W., et al. Follow-up recommendations for patients with stage I malignant melanoma. J Dermatol Surg Oncol. 20:1994;175-178.
33. Kosecoff J., Kanouse D.E., Rogers W.H., et al. Effects of National Institutes of Health consensus development program on physician practice. JAMA. 258:1987;2708-2713.